JENNIFER MASON: Open Payments
NPI 1972103810 · MIAMI, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 17 payments from 11 companies in 2025. Trend: 2023 $194 · 2024 $363 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Lilly USA, LLC | 2 | $44 |
| Amgen Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Tonix Medicines, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: JARDIANCE, OTEZLA, AIRSUPRA, UBRELVY, Kerendia, TONMYA, REXULTI, MOUNJARO.
Industry payments across OK — which companies pay providers there.
